| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ciclopirox | CTRPv2 | pan-cancer | AAC | -0.055 | 0.1 |
| mRNA | SR8278 | CTRPv2 | pan-cancer | AAC | 0.18 | 0.1 |
| mRNA | trifluoperazine | CTRPv2 | pan-cancer | AAC | -0.065 | 0.1 |
| mRNA | BRD-K04800985 | CTRPv2 | pan-cancer | AAC | 0.062 | 0.1 |
| mRNA | Oxaliplatin | CTRPv2 | pan-cancer | AAC | -0.054 | 0.1 |
| mRNA | Sildenafil | CTRPv2 | pan-cancer | AAC | -0.062 | 0.1 |
| mRNA | NVP-ADW742 | CTRPv2 | pan-cancer | AAC | -0.057 | 0.1 |
| mRNA | Compound 1541A | CTRPv2 | pan-cancer | AAC | 0.063 | 0.2 |
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | 0.058 | 0.2 |
| mRNA | skepinone-L | CTRPv2 | pan-cancer | AAC | -0.082 | 0.2 |